深圳首创“密网支架”省级集采！均价由11万元降至6万元

Core Points - The procurement of "flow-directed mesh stents" led by the Shenzhen Medical Insurance Bureau resulted in an average price reduction of 42.82%, with the highest reduction reaching 63.16% [1] - The average price of the stents decreased from approximately 110,000 yuan to about 60,000 yuan, significantly alleviating the financial burden on patients and allowing more patients to access better treatment [1] - The innovative procurement model involved a "post-reporting" method, ensuring that selected products better meet clinical needs and quality standards, while also providing new products ample time to enter the market [2] Group 1 - The procurement process was supported by the provincial medical insurance bureau and aimed to share the price reduction benefits across public medical institutions in Guangdong Province, potentially reducing patient medical expenses by 119 million yuan annually [1] - The procurement cycle was shortened by 50% through a collaborative approach that considered clinical demand, market share, and expert advice, stabilizing enterprise expectations [1] - Since its establishment, the Shenzhen Medical Insurance Bureau has implemented various measures to reduce patient costs, totaling 17.109 billion yuan [2]